EPA Greenlights Oil Ops Despite Eco Pushback in Colorado
Published Date: 4/10/2026
Notice
Summary
The EPA has decided not to block the air pollution permits for four Bonanza Creek Energy facilities in Colorado after reviewing a petition from an environmental group. This means the company can keep operating under the current permits, but the decision can be challenged in court by June 9, 2026. Local communities and the energy company are the main players affected by this ruling.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
Bonanza Creek Permits Remain Active
Bonanza Creek Energy can keep operating under four Clean Air Act operating permits (nos. 20OPWE417, 20OPWE418, 20OPWE419, 20OPWE420) for facilities in Weld County, Colorado because the EPA denied the May 19, 2025 petition. The EPA Administrator's order was signed December 10, 2025.
Local Petition Denial, Judicial Review Deadline
Residents and local stakeholders near the four Weld County, Colorado facilities learned the EPA denied a May 19, 2025 petition to object to those permits, so the permits stay in force. Anyone seeking judicial review of the denial must file a petition in the appropriate U.S. Court of Appeals by June 9, 2026.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-22082, Additional Reconsideration Standards of Performance for New, Reconstructed, and Modified Sources and Emissions Guidelines for Existing Sources: Oil and Natural Gas Sector Climate Review
The EPA is updating rules for oil and natural gas companies to fix issues from last year’s changes. They’re scrapping the Super Emitter Program, splitting well sites into clearer groups, and tweaking rules on leaks, equipment, and inspections. Companies should get ready to comment by December 16, 2026, as these updates could affect how they manage emissions and operate equipment.
2026-21155, Renewable Fuel Standard (RFS) Program: Reallocation of Additional 2025 Small Refinery Exemptions
The EPA is updating how it handles small refinery exemptions (SREs) for 2025 under the Renewable Fuel Standard. They’re deciding whether to spread the extra exemptions between 2026 and 2027 or give them all to 2027. This change might also push back the 2026 compliance deadline, affecting refiners and renewable fuel producers with potential timing and cost impacts.
2026-20849, Clean Water Act Hazardous Substance Facility Response Plans: Compliance Date Delay and Changes To Reflect Administration Policy
The EPA is giving facilities more time to meet new Clean Water Act rules for handling hazardous spills, pushing back the deadline to help them get ready. They’re also removing mentions of climate change and environmental justice to match new government policies. This delay helps facilities plan better without rushing and lets the EPA rethink the rules if needed.
2026-19071, Partial Repeal of the Carbon Pollution Standards for Fossil Fuel-Fired Electric Generating Units
The EPA is rolling back most of the 2024 rules that limited carbon pollution from fossil fuel power plants. This change affects coal and gas plants by easing some strict limits on emissions and carbon capture technology. The new rules kick in on November 16, 2026, potentially saving money for power plants but raising questions about pollution control.
2026-19072, Rescission of the Greenhouse Gas Findings for Fossil Fuel-Fired Power Plants and Repeal of Regulations for Power Plant Greenhouse Gas Emissions Under Clean Air Act Section 111
The EPA is proposing to cancel all greenhouse gas rules for fossil fuel power plants, saying the law doesn’t let them regulate these emissions for climate reasons. This change affects power plants across the U.S. and could impact future pollution limits and costs. Comments on this proposal are open until November 2, 2026, so now’s the time to speak up!
2026-18317, Updated Definition of “Waters of the United States”
The purpose of this supplemental notice of proposed rulemaking is for the U.S. Environmental Protection Agency (EPA) and the Department of the Army ("the agencies") to supplement and seek additional comment on certain aspects of an earlier proposal, published on November 20, 2025, to revise the regulations defining the scope of waters federally covered under the Clean Water Act in light of the U.S. Supreme Court's 2023 decision in Sackett v. Environmental Protection Agency. As stated in the agencies' November 20, 2025 Notice of Proposed Rulemaking (NPRM), the agencies intend for this rulemaking to provide greater regulatory certainty and increase Clean Water Act program predictability and consistency by clarifying the definition of "waters of the United States." After consideration of the public comments received on the NPRM, the agencies are issuing this notice to supplement the NPRM with additional regulatory options on certain aspects of the proposed rule.
Previous / Next Documents
Previous: 2026-06906, Agency Information Collection Activities; Proposed Collection; Comment Request; Premarket Approval of Medical Devices
The FDA wants your thoughts on how it collects info for approving new medical devices before they hit the market. This affects device makers who must provide detailed info to prove their products are safe and effective. You’ve got until June 9, 2026, to share your comments, helping shape a smoother, clearer approval process without extra costs or delays.
Next: 2026-06911, GlaxoSmithKline; Withdrawal of Approval of a New Drug Application for Wellcovorin (Leucovorin Calcium) Tablets, EQ 5 mg Base and EQ 25 mg Base
GlaxoSmithKline has stopped selling Wellcovorin tablets and asked the FDA to withdraw its approval for these drugs as of April 10, 2026. This means Wellcovorin tablets (5 mg and 25 mg) can no longer be legally sold or shipped, but pharmacies can use up any leftover stock until it runs out or expires. If needed, GSK can apply again in the future to bring the drug back.